News
21
2023-03
BrosMed Announced CE MDR Approval of Tiche™ 0.035”High Pressure PTA Balloon Dilatation Catheter
March 21, 2023 — BrosMed today announced that it has received certification under the European Medical Device Regulation (MDR) for its Tiche™ 0.035” High Pressure PTA Balloon Dilatation Catheter, which is designed for the treatment of severely calcified peripheral vascular disease and challenging arteriovenous (AV) access cases.
2023-03-21
29
2022-11
BrosMed Medical Announced Japanese Approval and Launch of Rokku Exchange Device In Japan Market
Guangdong, China [Nov. 24, 2022] – BrosMed Medical announced its exchange device has received the Japan PMDA approval.
2022-11-29
01
2022-03
BrosMed Enters 10th Anniversary Year
BrosMed Medical Co., Ltd.(“BrosMed”) is celebrating its 10-year anniversary today!
2022-03-01
01
2021-06
Brosmed received CE mark approval for POT™ PTCA balloon catheter
Sittard, Netherlands [May 24, 2021] –Brosmed received CE Mark approval in the European Union for its POT™ PTCA balloon catheter, a dedicated balloon for the proximal and distal optimization techniques (PDOT).
2021-06-01
26
2021-05
BrosMed received CE mark approval for Pronavi™ Microcatheter
Sittard, Netherlands [May 26, 2021] –BrosMed received CE Mark approval in the European Union for its Pronavi™ Microcatheter. This device is indicated for use in both coronary and peripheral interventions.
2021-05-26
24
2021-05
Guangdong ,China [May 24 , 2021] – Brosmed Co., Ltd. has received a 510(k) clearance from the U.S. Food & Drug Administration for its Artimes™ Pro PTCA balloon catheter.
2021-05-24
11
2021-05
Optimize Percutaneous Coronary Intervention with a Scoring Balloon Webinar
Guangdong [May 11 , 2021] – Brosmed Medical Ltd. hosted its first global webinar: Optimize Percutaneous Coronary Intervention with a Scoring Balloon on April 27th 2021. This webinar was hosted by Prof. Stephane Carlier from Belgium together with Dr. Bernardo Cortese from Italy and Prof. Jo Dens from Hart Center Genk in Belgium.
2021-05-11
